Answers are grounded in this paper and cite their sources.
This study aimed to determine the effectiveness of postoperative adjuvant lenvatinib + PD-1 blockade for patients with early-stage hepatocellular carcinoma (HCC) with microvascular invasion (MVI).
No takes yet. Share an insight, caveat, or question.
Danzeng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: